{"name":"Suzhou Ribo Life Science Co. Ltd.","slug":"suzhou-ribo-life-science-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNWkpSUmdEVXNISWNIcXpySTZwWnRwdWdWOS1VajZudnA0eG9nX3dJMHc0Y2Z5VHY0Q1JCWTAycnZQaTEySm5xdjFKMExKcjBZcXJWelhDM3dMU09UUjZHR0xReXQ1WUthTXQ2UTBWVVp5b1VQYmRsb1p1N3RlVnNGWVZyLXUwZ1M3VXRoVmF1anl0UUY3?oc=5","date":"2026-02-12","type":"pipeline","source":"Finviz","summary":"MDGL Strengthens MASH Franchise With New Genetic Approaches - Finviz","headline":"MDGL Strengthens MASH Franchise With New Genetic Approaches","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQbUdfbVpOS1BtMHNnV0xxR1ZZZURNQkJTU2NwS2JFd2Q5VFRGYUttSWV6OTJSQVZNbG81Y0xfaFdBUnNMUXdLVXE1aENUVUZSZkhjazNrcWE3YlNQVW9CSGVRR01Qako5WjZ6MjBSeTNGTy1oUEp4YkhkMzRlcFA5NnZsUXZIc0E1cGtGdnRuR2xQYUZZSlpEYkFLd09FN2lfQ3ppSUlXR1VGVGwyekdz?oc=5","date":"2026-02-12","type":"deal","source":"The Business Journals","summary":"Conshohocken firm enters into potential $4.5B deal to expand drug pipeline - The Business Journals","headline":"Conshohocken firm enters into potential $4.5B deal to expand drug pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxQd2FISzFkSVRnaUk4SVpxVnNZaWpCU3FVdVVIOUt6YnFDTmloSG5mTWxhTVVRV3FBRlEtM1J0aGhJUDVaZW5pblZ4cjZYSHZpX3NnSWFHVGJCU2JjbUVPUk9nZUJudHFSTnkzMGJyT2Q2QUFKQVpCN1l6SnZjSWhFeERyQ3Y4OTJadExYeUtlLTBPU21WZVU1QzVRLVFyU0dzeUxpVnZKZ2YxOHVZeW04ZFlsYndTLTFDMWFkMmF0RG9QVVZMZzRsaGhWbk1zNFVaZVc0b24zUlowcGNBdVhWb19IejI0a2pXU1YyQ1AzdG1QUmNlVGxhRFBrSGNaay1CQ0w4RGNraUs?oc=5","date":"2026-02-11","type":"pipeline","source":"PR Newswire","summary":"Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH - PR Newswire","headline":"Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQYXlqZHBkYzhqMWgzOV9IZWlZTV9YOVI0eXZ3bmRlU1I0WGtfd1F4MzJrY2UxajZ6VDNaYWhZYTBIdEx0b21tUVoyb09ZbEZ5UjUwb3h4ZVNfb295bUZCaS1pODFNSkVId04yVFdGdkRsN0NTREFJVWx1MFNOamg2LS1lNk9naXpKZ3c?oc=5","date":"2026-02-11","type":"deal","source":"BioWorld News","summary":"Madrigal licenses six Ribo siRNA programs - BioWorld News","headline":"Madrigal licenses six Ribo siRNA programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxORi05Y3JFQThaTmlwYkVXOVozQ0h6YkdTWEQ4X2cyYkpiZ1ZEZUxObGJDSW5OUG1NQ2UzcVlXV3dHRmN3T3hoSThIQXBWRF9qbWFBTDMtSUNCelY4R0VnaDgxSjlyaDVBNjRHV3hkTHh4dlBVbW9Fb1pLWmxqMHduQlJEc0doNE5VZ2EwT1dBamZFbUEzYlB1MVd4YlpFVy1QUEdjYlY2V1lWZlhqa2VHMFFsWmhKOXY1ZmF4VXdobmpudHhwT2JPVnI1S2xwY0hDXzVLR0RoLTV1T20wWGZpOGhfNzRVMWc?oc=5","date":"2026-02-11","type":"deal","source":"Citeline News & Insights","summary":"Madrigal Continues Building Out MASH Pipeline With Ribo Life Science Deal - Citeline News & Insights","headline":"Madrigal Continues Building Out MASH Pipeline With Ribo Life Science Deal - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxOUkwzWE45aWVXRDBsemE3WFQwZ2huVEVZWkRnclZ3S2NkcmNMcWdYQW9KZWRWNzYyX2xwRVVjb0F4V1JxZHJuSVJrNFV0WDFJMlVpUGJQMzRFLWhUVW5raUJfNjFuczJlM1lRaVlXYnp4Zndxbkd1M253LS1EMnEyYUxndlVCUFM1ZGota2dKd0U4UjJHV3ZmN3IwaGpKZHB0am1QWjhTbjVCWXRHNFpnb1dBd2FZYjA1bFpOVFNLbG9zXzdwcXk1dHBtTWI1Z2hvNHlySzFuQ1gtMjhIZlZZbE1kME1vS01NRDF2SFp4c3hXcEJWeFBoWUNFQXZHTGtkakd2TDJZSUZTRmdUOVFrcQ?oc=5","date":"2026-02-11","type":"pipeline","source":"globenewswire.com","summary":"Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs - globenewswire.com","headline":"Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNTTFKcFVYZGc5UXhCMTZ6X0Rmc0ZldkxoeDlETzRlT0JQS0ltN0RZdE52Y0UtWFVKdzc4d3pEdG1fWGVtdXVlcmJ3MlNlTktWcWw0cHRycFlqS0tkdzlVb2hOTVZWcHJLS0NOLWhBcDJmU3VsNGpPaXNsNDJtMUJuZG9BZUMyZUpxdlE5YVFxUEo3TVZ4d2lpV0x2MGpVWHlnOG9wdENLa2lCNjMwd3ZiZzBzMEdHRDFPVjRZY3NHdG4?oc=5","date":"2026-02-11","type":"pipeline","source":"Stock Titan","summary":"Madrigal signs RNA liver drug pact with Ribo worth up to $4.4B - Stock Titan","headline":"Madrigal signs RNA liver drug pact with Ribo worth up to $4.4B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNQ1l3dWtFOWI1cWo1Q2ZWLS1Yc3BuNzVKeTJzemVaczJYMjJzc1V0NG5PU2xseHpfYkFqNzBta3hTSV91SjBEcnNTdURZWVFfNHhUaFp1V1RVYkhJQ1VPSTE1Vk9MOS1iV3RBZWVBUE1MVU1LOFl3ODlRTGpJMERuaGhaU0QxQ1lyTzEtNG9OMTlFTDZIV29yZ1NoeU10UzlfVVpHc0I2aEEtY3BPaU5JdVhEUUFKZ0p2TS1JWVF6WkxZVlZqWXFIOEMwWm5zZFBrVkUydTlsMDNwZFFEVXRubXBybW8?oc=5","date":"2026-01-09","type":"pipeline","source":"PR Newswire","summary":"Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange - PR Newswire","headline":"Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOcmk4UFRtX3c5ZTIzSEk2VGJ4b1VfQkhnVUoxSE5tamlUYXFoVUI3V190UjF1MmJWenJheWd3aHMzS2taakxSWk81OWNZdXA0SWpRSE5UT0VZd2s2SzgxM0lndlJMM2lETENkTGx0cFlRTjFBSmdJODhYazdmZW1zSjRHWl9nQUlySXpWbFh6TERrdUp4MUp4WUQ4eS03Y2pTWEtR?oc=5","date":"2026-01-02","type":"pipeline","source":"thebambooworks.com","summary":"Hong Kong to welcome world-leading siRNA company as Ribo launches its IPO - thebambooworks.com","headline":"Hong Kong to welcome world-leading siRNA company as Ribo launches its IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOMTBycmFDa3VYTWMxaWRmNE5qZTV4YWQzcnh2NHRmVW5kRm44WjhnRk84WnR6QXNIOWk3SG40UTNKbmtyRU1lMTlxTlVILWxOdUQ4UlZDcUlpb01OVVZROXdPaGQ3TmlCUEhrRlFCVk9yaUJWYzlFa3FqaVhnNlVuMndUdUgyWHlxR09zaC1KdjlockNPUmRVczQ5dkNsQ3dTZDFKSg?oc=5","date":"2024-01-09","type":"deal","source":"BioWorld News","summary":"Argo, Novartis sign two deals for CV assets for potentially $4B+ - BioWorld News","headline":"Argo, Novartis sign two deals for CV assets for potentially $4B+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQUU1uQ201UzBkNlNNRFhoWHVfLWlPVUc5alVZalBub3lBSHZiNGNpS0c2WWJ3MUphV0ZuVVlvbHlRdUt2LXRXWWhlWmY0QWQyQ3VXU3lUSzZHcTVzWTJ6SjlRRUs1ckltMVcydHJrUHotUkd1MGpKaDJzMW1MNlNOUmVXandSSTRjTVV2Q2I2cnJyM3F1R2lLZDkxQUo?oc=5","date":"2024-01-03","type":"deal","source":"Contract Pharma","summary":"Ribo, Boehringer Ingelheim Partner on Liver Disease Treatment - Contract Pharma","headline":"Ribo, Boehringer Ingelheim Partner on Liver Disease Treatment","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}